Eli Lilly and Co (LLY)

Add to Watchlists
Create an Alert
Quickflows
154.17 +1.70  +1.11% NYSE Sep 18, 20:00 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All LLY News

News

View All Events

Events

Date Type Description
10/27/2020 09:00 EDT Misc Eli Lilly and Co Third Quarter Earnings Conference Call for 2020
10/27/2020 Earnings Eli Lilly and Co Third Quarter Earnings in 2020 Release
08/13/2020 Dividends Amount: 0.74, Declared Date: Jul 15 2020, Pay Date: Sep 10 2020
07/30/2020 09:00 EDT Misc Eli Lilly and Co Second Quarter Earnings Conference Call for 2020
07/30/2020 Earnings Eli Lilly and Co Second Quarter Earnings in 2020 Release
05/14/2020 Dividends Amount: 0.74, Declared Date: May 04 2020, Pay Date: Jun 10 2020
05/04/2020 11:00 EDT Misc Eli Lilly and Co Annual General Meeting for 2019
04/23/2020 09:00 EDT Misc Eli Lilly and Co First Quarter Earnings Conference Call for 2020
04/23/2020 Earnings Eli Lilly and Co First Quarter Earnings in 2020 Release
02/19/2020 Misc Eli Lilly and Co Annual Report for 2019
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 22.95B
Total Expenses (TTM) 17.12B
Net Income (TTM) 5.618B

Balance Sheet View Statement

Total Assets (Quarterly) 41.97B
Total Liabilities (Quarterly) 37.70B
Shareholders Equity (Quarterly) 4.093B

Cash Flow Statement View Statement

Cash from Operations (TTM) 6.352B
Cash from Investing (TTM) -1.736B
Cash from Financing (TTM) -4.373B

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.lilly.com
  • Investor Relations URL: https://investor.lilly.com/
  • HQ State/Province: Indiana
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Large Cap/Blend
  • Next Earnings Release: Oct. 27, 2020
  • Last Earnings Release: Jul. 30, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Aug. 13, 2020
  • Description: Eli Lilly is a drug company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 154.17
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
VPMCX Vanguard PRIMECAP Inv 5.81%
VPCCX Vanguard PRIMECAP Core Inv 5.04%
VHCOX Vanguard Capital Opportunity Inv 5.01%
VGHCX Vanguard Health Care Inv 3.64%
XLV Health Care Select Sector SPDR® ETF 3.25%
VHT Vanguard Health Care ETF 2.72%
MTUM iShares MSCI USA Momentum Factor ETF 2.18%
DGRW WisdomTree US Quality Dividend Gr ETF 1.68%
HRCAX Harbor Capital Appreciation Admin 1.51%
USMV iShares MSCI USA Min Vol Factor ETF 1.18%
VIVAX Vanguard Value Index Inv 1.02%
VTV Vanguard Value ETF 1.02%

Comparables

Edit
REGN Regeneron Pharmaceuticals Inc
MRNA Moderna Inc
AMGN Amgen Inc
GILD Gilead Sciences Inc
JNJ Johnson & Johnson

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.